Sr. Director, Strategy - Oncology & Multispecialty

McKesson•Alpharetta, GA
•Hybrid

About The Position

The Sr. Director, Strategy (Oncology & Multispecialty) is a senior-level individual contributor who owns strategic initiatives end-to-end, from framing problems and designing approaches through analysis, recommendations, stakeholder syndication, decisions, and hand-off to execution owners. The role supports initiatives across provider-facing commercial segments—including GPO, specialty distribution, specialty pharmacy, alternate site infusion, and practice management—and biopharma-facing segments, including clinical trial site management, real-world evidence, and clinicogenomic data. Many initiatives address strategic questions at the intersection of these segments. The Sr. Director leads cross-functional initiative teams and guides Senior Managers, analysts, and business partners through structured problem solving, analytical direction, and high-quality feedback. Formal performance and development accountability remains with people leaders. The role also provides expertise on specialty care and biopharma services value-chain economics, directs financial analysis, partners with senior business and customer leaders, communicates recommendations, coaches colleagues, and supports early implementation of approved recommendations. The role offers location flexibility across the United States. Candidates based in the Dallas–Fort Worth area, or residing within 50 miles of Irving, Texas, are expected to work onsite at the Las Colinas office two days per week, with remaining days remote. Travel may be required up to 25% of the time.

Requirements

  • 10 or more years of progressive experience in strategy, including engagement leadership at a top-tier strategy consulting firm or equivalent project leadership in a corporate strategy function.
  • Experience in healthcare services, specialty care, life sciences, health data, or adjacent industries, with the ability to build working fluency quickly in complex, clinically grounded value-chain economics.
  • Track record of leading cross-functional strategic projects end-to-end that resulted in concrete decisions and measurable action.
  • Demonstrated ability to lead and develop small analytical teams.
  • Executive presence and demonstrated effectiveness presenting to and influencing senior leaders.
  • Currently authorized to work in the United States on a full-time basis without requiring employer immigration support or sponsorship now or in the future.
  • Ability to travel up to 25% of the time.
  • Ability to meet general office demands.

Nice To Haves

  • Structures problems using core problem-solving disciplines and translates ambiguity into hypotheses, workplans, and decision paths, while incorporating qualitative, people, and relationship-based problem solving.
  • Working knowledge of specialty care and biopharma services economics, including buy-and-bill, 340B, specialty pharmacy, infusion, practice management fees, and CRO/RWE business models, applied as an analytical lens.
  • Ability to synthesize implications into well-syndicated recommendations framed as genuine choices with explicit trade-offs, while controlling quality and process across an initiative.
  • Ability to constructively challenge stakeholder and team assumptions, bring new insights, and build trust-based relationships that make challenge welcome.
  • Ability to coach team members in a strengths-based way, solicit feedback, and create conditions for high performance and team health.
  • Ability to prepare well-structured documents with minimal guidance, present to audiences of all sizes, foster constructive dialogue, and balance asking with telling.
  • Comfort developing and communicating recommendations amid uncertainty, incomplete information, and business-driven timelines, including making and supporting assumptions as needed.

Responsibilities

  • Lead strategic initiatives end-to-end, from problem definition and workplan design through analysis, recommendation development, stakeholder syndication, and hand-off to execution owners.
  • Structure ambiguous or contested problems into clear hypotheses, workplans, and decision paths, with rigorous problem definition, logic, and evidence.
  • Develop recommendations that present genuine choices and explicit trade-offs, grounded in the financial architecture of specialty care and biopharma services markets.
  • Prepare and lead productive problem-solving sessions with business partners across both franchises, engaging stakeholders in joint problem solving.
  • Serve as a knowledgeable resource on specialty care and biopharma services value-chain economics, including buy-and-bill, 340B, GPO and distribution economics, specialty pharmacy P&Ls, infusion site-of-care dynamics, clinical research, and RWE businesses.
  • Direct and quality-control team financial models, identify key assumptions, and translate market shifts into quantified P&L implications.
  • Analyze financial and competitive consequences of regulatory and policy developments, including 340B reform, Part B reimbursement policy, oncology care model evolution, biosimilar adoption, and FDA policy on RWE, as relevant to assigned initiatives.
  • Contribute to scenario analyses of structural moves by value-chain participants, including practice consolidation, PBM vertical integration, health system expansion into community oncology, and technology platform entry.
  • Act as a thought partner to business and customer leaders, constructively challenge assumptions, and surface important facts early.
  • Consider organizational culture and stakeholder perspectives, including clinical and operational leaders, when crafting executable recommendations.
  • Develop stakeholder engagement plans covering fact-finding through solution development to build alignment throughout the work.
  • Deliver compelling written and oral communications to senior business audiences; lead with key messages, present persuasively, and tailor materials to the audience.
  • Listen actively, ask questions, and create value in meetings, discussions, and workshops involving clinical oncology, practice operations, and data science.
  • Partner with and direct teams, scope work against team capacity, and deliver high-quality output without undue crunch.
  • Coach team members using a strengths-based approach, provide timely and insightful feedback, and create development opportunities.
  • Contribute to an inclusive team climate and function-building efforts, including recruiting and knowledge development.
  • Translate approved recommendations into implementation roadmaps with owners, milestones, and metrics, and support transformation programs during early execution.
  • Create feedback loops that surface early execution signals and inform the strategic logic.

Benefits

  • Competitive compensation package as part of Total Rewards.
  • Annual bonus or long-term incentive opportunities may be offered.
© 2026 Teal Labs, Inc
Privacy PolicyTerms of Service